JP2000511782A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511782A5
JP2000511782A5 JP1998545569A JP54556998A JP2000511782A5 JP 2000511782 A5 JP2000511782 A5 JP 2000511782A5 JP 1998545569 A JP1998545569 A JP 1998545569A JP 54556998 A JP54556998 A JP 54556998A JP 2000511782 A5 JP2000511782 A5 JP 2000511782A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998545569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511782A (ja
JP4099239B2 (ja
Filing date
Publication date
Priority claimed from SE9701127A external-priority patent/SE9701127D0/xx
Application filed filed Critical
Publication of JP2000511782A publication Critical patent/JP2000511782A/ja
Publication of JP2000511782A5 publication Critical patent/JP2000511782A5/ja
Application granted granted Critical
Publication of JP4099239B2 publication Critical patent/JP4099239B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54556998A 1997-03-26 1998-03-26 GALα1、3GALエピトープを有する抗原性融合タンパク質 Expired - Fee Related JP4099239B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9701127-4 1997-03-26
SE9701127A SE9701127D0 (sv) 1997-03-26 1997-03-26 Antigenic fusionprotein carrying GALal, 3GAL epitopes
PCT/SE1998/000555 WO1998042750A1 (en) 1997-03-26 1998-03-26 ANTIGENIC FUSIONPROTEIN CARRYING GALα1,3GAL EPITOPES

Publications (3)

Publication Number Publication Date
JP2000511782A JP2000511782A (ja) 2000-09-12
JP2000511782A5 true JP2000511782A5 (cg-RX-API-DMAC7.html) 2005-11-10
JP4099239B2 JP4099239B2 (ja) 2008-06-11

Family

ID=20406335

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54556998A Expired - Fee Related JP4099239B2 (ja) 1997-03-26 1998-03-26 GALα1、3GALエピトープを有する抗原性融合タンパク質

Country Status (12)

Country Link
US (3) US6943239B2 (cg-RX-API-DMAC7.html)
EP (2) EP0923606B1 (cg-RX-API-DMAC7.html)
JP (1) JP4099239B2 (cg-RX-API-DMAC7.html)
AT (1) ATE315047T1 (cg-RX-API-DMAC7.html)
AU (1) AU751760B2 (cg-RX-API-DMAC7.html)
BR (1) BR9804826A (cg-RX-API-DMAC7.html)
CA (1) CA2255765A1 (cg-RX-API-DMAC7.html)
DE (1) DE69833106T2 (cg-RX-API-DMAC7.html)
DK (1) DK0923606T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258297T3 (cg-RX-API-DMAC7.html)
SE (1) SE9701127D0 (cg-RX-API-DMAC7.html)
WO (1) WO1998042750A1 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010201A2 (en) * 2001-07-20 2003-02-06 Absorber, Ab Blood group antigen fusion polypeptides and methods of use thereof
US20040009546A1 (en) * 2002-04-22 2004-01-15 Jan Holgersson Compositions and methods for inhibiting microbial adhesion
ATE551069T1 (de) * 2002-04-22 2012-04-15 Recopharma Ab Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
WO2003097658A2 (en) 2002-05-16 2003-11-27 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
EP1539251A4 (en) * 2002-07-03 2009-02-25 Glycomimetics Inc COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF MEDICAL DISEASES WITH ANGIOGENESIS
CA2495743C (en) * 2002-08-09 2011-01-25 Recopharma Ab Fusion proteins and methods of producing same
US20050076759A1 (en) * 2003-10-08 2005-04-14 Brian Westfall Linear saw with stab-cut bevel capability
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
EP1689776A2 (en) * 2003-11-12 2006-08-16 Wisconsin Alumni Research Foundation Equine p-selectin glycoprotein ligand-1 and uses thereof
DE602004011272T2 (de) * 2003-11-19 2008-12-24 Glycomimetics, Inc. Spezifischer antagonist sowohl für e- als auch p-selektine
US20050187171A1 (en) * 2003-11-19 2005-08-25 Glycomimetics, Inc. Glycomimetic antagonists for both E-and P-selectins
WO2006001348A1 (ja) * 2004-06-23 2006-01-05 Japan Science And Technology Agency 浸潤抑制及び細胞殺傷剤
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
DK1928892T3 (da) * 2005-08-09 2012-01-30 Glycomimetics Inc Glycomimetiske inhibitorer af PA-IL-lectin PA-IIL-lectin eller begge lectiner fra pseudomonas
ES2397850T3 (es) 2005-09-02 2013-03-11 Glycomimetics, Inc. Inhibidores de pan-selectina heterobifuncionales
WO2007033221A2 (en) * 2005-09-13 2007-03-22 The General Hospital Corporation Methods and compositions for inhibition of immune responses
DK2264060T3 (da) * 2006-01-26 2014-07-28 Recopharma Ab Sammensætninger og fremgangsmåder til inhibering af viral adhæsion
US20070178447A1 (en) * 2006-01-31 2007-08-02 Bethyl Laboratories, Inc. Method for decreasing interference in results of immunochemical methods
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
WO2008060378A2 (en) 2006-10-12 2008-05-22 Glycomimetics, Inc. Glycomimetic replacements for hexoses and n-acetyl hexosamines
US7998486B2 (en) 2006-10-25 2011-08-16 Newlink Genetics Corporation Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
EP2457573A1 (en) * 2007-02-09 2012-05-30 GlycoMimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
AU2009257536B2 (en) * 2008-06-13 2015-07-02 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
CN102421441B (zh) 2009-05-01 2015-04-01 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
CN103501804A (zh) * 2010-12-21 2014-01-08 雷科制药公司 眼泪替代物
CN104039805B (zh) 2011-12-22 2016-11-16 糖模拟物有限公司 E-选择蛋白拮抗剂化合物、组合物及使用方法
SI2928476T1 (en) 2012-12-07 2018-06-29 Glycomimetics, Inc. COMPONENTS, INSTALLATIONS AND PROCEDURES OF THE APPLICATION OF E-SELECTINE OF ANTAGONISTS FOR THE MOBILIZATION OF HEMATOPOETIC CELLS
JP6689854B2 (ja) 2014-12-03 2020-04-28 グリコミメティクス, インコーポレイテッド E−セレクチンおよびcxcr4ケモカイン受容体のヘテロ二官能性阻害剤
US11045485B2 (en) 2016-01-22 2021-06-29 Glycomimetics, Inc. Glycomimetic inhibitors of PA-IL and PA-IIL lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
WO2018031445A1 (en) 2016-08-08 2018-02-15 Glycomimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
KR102653723B1 (ko) 2016-10-07 2024-04-01 글리코미메틱스, 인크. 매우 강력한 다량체성 e-셀렉틴 길항물질
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス, インコーポレイテッド E-セレクチンアンタゴニストとしてのガラクトピラノシル-シクロヘキシル誘導体
US11712446B2 (en) 2017-11-30 2023-08-01 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
BR112020013198A2 (pt) 2017-12-29 2020-12-01 Glycomimetics, Inc. inibidores heterobifuncionais de e-selectina e galectina-3
US11707474B2 (en) 2018-03-05 2023-07-25 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US20210260250A1 (en) * 2018-06-12 2021-08-26 Rush University Medical Center Methods for Enhanced Endothelialization of Implanted Material
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110518C (en) * 1991-06-27 2007-05-22 Peter S. Linsley Ctla4 receptor, fusion proteins containing it and uses thereof
DK0666914T3 (da) 1992-10-23 2004-04-13 Inst Genetics Llc Hidtil ukendt P-selectin-ligandprotein
EP1621627A3 (en) 1993-03-16 2006-06-07 The Austin Research Institute Use of porcine gala (1,3) galactosyl transferase in xenograft therapies
GB9517758D0 (en) * 1995-08-31 1995-11-01 Imutran Ltd Compositions and their uses

Similar Documents

Publication Publication Date Title
JP2002502276A5 (cg-RX-API-DMAC7.html)
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000509942A5 (cg-RX-API-DMAC7.html)
JP2000509912A5 (cg-RX-API-DMAC7.html)
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2002500533A5 (cg-RX-API-DMAC7.html)
JP2001511276A5 (cg-RX-API-DMAC7.html)
JP2001523135A5 (cg-RX-API-DMAC7.html)
JP2000507369A5 (cg-RX-API-DMAC7.html)
JP2000507433A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508022A5 (cg-RX-API-DMAC7.html)
JP2002515071A5 (cg-RX-API-DMAC7.html)
JP2000511782A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2000509804A5 (cg-RX-API-DMAC7.html)
JP2001518853A5 (cg-RX-API-DMAC7.html)
JP2000509853A5 (cg-RX-API-DMAC7.html)
JP2000509755A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2000510247A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2000509818A5 (cg-RX-API-DMAC7.html)
JP2001527481A5 (cg-RX-API-DMAC7.html)